Is Dicerna Pharmaceuticals (DRNA) a Smart Long-term Buy?
Baron Health Care Fund recently published its third-quarter commentary – a copy of which can be downloaded here. During the third quarter of 2020, the Baron Health Care Fund returned 11.64% (institutional shares). In comparison, the benchmark S&P 500 Index was up 8.93%, while the Russell 3000 Health Care Index was up 6.48%. You should check out Baron’s top 5 stock picks for investors to buy right now, which could be the biggest winners of 2021.
In the Q3 2020 Investor Letter, Baron Health Care Fund highlighted a few stocks and Dicerna Pharmaceuticals Inc (NASDAQ:DRNA) is one of them. Dicerna Pharmaceuticals Inc (NASDAQ:DRNA) is a biotechnology company. Year-to-date, Dicerna Pharmaceuticals Inc (NASDAQ:DRNA) stock gained 9.0% and on December 10th it had a closing price of $24.02. Here is what Baron Health Care Fund said:
Is Schrodinger (SDGR) a Smart Long-term Buy?
Baron Health Care Fund recently published its third-quarter commentary – a copy of which can be downloaded here. During the third quarter of 2020, the Baron Health Care Fund returned 11.64% (institutional shares). In comparison, the benchmark S&P 500 Index was up 8.93%, while the Russell 3000 Health Care Index was up 6.48%. You should check out Baron’s top 5 stock picks for investors to buy right now, which could be the biggest winners of 2021.
In the Q3 2020 Investor Letter, Baron Health Care Fund highlighted a few stocks and Schrodinger Inc. (NASDAQ:SDGR) is one of them. Schrodinger Inc. (NASDAQ:SDGR) is a life sciences and materials science company. In the last three months, Schrodinger Inc. (NASDAQ:SDGR) stock gained 23.3% and on December 9th it had a closing price of $66.21. Here is what Baron Health Care Fund said: